INNOCAN PHARMA CORP (INNPF:OTCMKTS)
$1.4 -0.22 (-13.5802%)
Analysed INNOCAN PHARMA CORP (INNPF:OTCMKTS) News Sources
Innocan Pharma LPT-CBD is featured in Pain Medicine News
06-05-2026
yahoo.com
Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth
29-07-2026
yahoo.com
Over 100,000 Positive Verified Customer Reviews Reflect Growing Consumer Trust
05-08-2026
yahoo.com
Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)
31-08-2026
yahoo.com
Innocan Pharma Announces Private Placement of Units
09-09-2026
yahoo.com
Innocan Pharma Announces First Tranche Closing of Private Placement of Units
23-09-2026
yahoo.com
VALITIC™ Expands Retail Industry Visibility Through Shoptalk Fall 2026 in Nashville, USA
29-09-2026
yahoo.com
VALITIC™ Featured by BuzzFeed for "Magical Results," Further Strengthening Consumer Brand Momentum
01-10-2026
yahoo.com
VALITIC™ Launches Direct-to-Consumer Website, Laying Groundwork for U.S. Holiday Campaign
08-10-2026
yahoo.com
Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
27-05-2026
yahoo.com
What is the current price of INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The current price of INNOCAN PHARMA CORP (INNPF:OTCMKTS) is $1.4.
INNOCAN PHARMA CORP (INNPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOCAN PHARMA CORP (INNPF:OTCMKTS) since the previous trading day is $-0.22.
INNOCAN PHARMA CORP (INNPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOCAN PHARMA CORP (INNPF:OTCMKTS) since the previous trading day is -13.5802%.
What is the most recent average sentiment score for INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The most recent average sentiment score for INNOCAN PHARMA CORP (INNPF:OTCMKTS) is 65 out of 100.
What is the most recent average sentiment for INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The most recent sentiment for INNOCAN PHARMA CORP (INNPF:OTCMKTS) is .
SEC-8K** Filing Available For INNOCAN PHARMA CORP (INNPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.